$Anifrolumab for the treatment of refractory chilblain lupus erythematosus$

Anifrolumab for the treatment of refractory chilblain lupus erythematosus

Bibliographic Details
Main Authors:	Michael J. Woodbury, BS, Katherine Nabel Smith, PhD, Jeffrey S. Smith, MD, PhD, Joseph F. Merola, MD, MMSc
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	JAAD Case Reports
Subjects:	anifrolumab chilblain lupus erythematosus type I interferon
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512623004113

Internet